Literature DB >> 16214917

Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas?

Terryl J Hartman1, Binbing Yu, Paul S Albert, Martha L Slattery, Electra Paskett, James Walter Kikendall, Frank Iber, Brenda K Brewer, Arthur Schatzkin, Elaine Lanza.   

Abstract

The Polyp Prevention Trial was designed to evaluate the effects of a high-fiber (18 g/1,000 kcal), high-fruit and -vegetable (3.5 servings/1,000 kcal), low-fat (20% energy) diet on recurrence of adenomatous polyps. Participants > or =35 years of age, with histologically confirmed colorectal adenoma(s) removed in the prior 6 months, were randomized to the intervention or control group. Demographic, dietary, and clinical information, including use of nonsteroidal anti-inflammatory drugs (NSAID), was collected at baseline and four annual visits. Adenoma recurrence was found in 754 of 1,905 participants and was not significantly different between groups. NSAID use was associated with a significant reduction in recurrence [odds ratio (OR), 0.77; 95% confidence interval (95% CI), 0.63-0.95]. In this analysis, NSAIDs modified the association between the intervention and recurrence at baseline (P = 0.02) and throughout the trial (P = 0.008). Among participants who did not use NSAIDs, the intervention was in the protective direction but did not achieve statistical significance (OR, 0.87; 95% CI, 0.69-1.09). The intervention was protective among males who did not use NSAIDs at baseline (OR, 0.71; 95% CI, 0.54-0.94), but not among NSAIDs users (OR, 1.09; 95% CI, 0.74-1.62). For females, corresponding OR estimates were 1.28 (95% CI, 0.86-1.90) and 2.30 (95% CI, 1.24-4.27), respectively. The protective association observed for NSAID use was stronger among control (OR, 0.63; 95% CI, 0.47-0.84) than for intervention group participants (OR, 0.97; 95% CI, 0.74-1.28). These results should be interpreted cautiously given that they may have arisen by chance in the course of examining multiple associations and Polyp Prevention Trial study participants were not randomly assigned to both dietary intervention and NSAID use. Nevertheless, our results suggest that adopting a low-fat, high-fiber diet rich in fruits and vegetables may lower the risk of colorectal adenoma recurrence among individuals who do not regularly use NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214917     DOI: 10.1158/1055-9965.EPI-05-0333

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  A healthy lifestyle index is associated with reduced risk of colorectal adenomatous polyps among non-users of non-steroidal anti-inflammatory drugs.

Authors:  Fred K Tabung; Susan E Steck; James B Burch; Chin-Fu Chen; Hongmei Zhang; Thomas G Hurley; Philip Cavicchia; Melannie Alexander; Nitin Shivappa; Kim E Creek; Stephen C Lloyd; James R Hebert
Journal:  J Prim Prev       Date:  2015-02

2.  Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Matthew R Young; Elaine Lanza; Arthur Schatzkin; Nancy H Colburn; Amanda J Cross
Journal:  Eur J Cancer Prev       Date:  2011-03       Impact factor: 2.497

3.  The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative.

Authors:  Fred K Tabung; Susan E Steck; Yunsheng Ma; Angela D Liese; Jiajia Zhang; Bette Caan; Lifang Hou; Karen C Johnson; Yasmin Mossavar-Rahmani; Nitin Shivappa; Jean Wactawski-Wende; Judith K Ockene; James R Hebert
Journal:  Cancer Causes Control       Date:  2014-12-31       Impact factor: 2.506

4.  Fruit and vegetable intakes are associated with lower risk of colorectal adenomas.

Authors:  Huiyun Wu; Qi Dai; Martha J Shrubsole; Reid M Ness; David Schlundt; Walter E Smalley; Heidi Chen; Ming Li; Yu Shyr; Wei Zheng
Journal:  J Nutr       Date:  2008-12-17       Impact factor: 4.798

Review 5.  Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Authors:  Martha L Slattery; F A Fitzpatrick
Journal:  Cancer Prev Res (Phila)       Date:  2009-11

6.  Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.

Authors:  Hemant K Roy; Vladimir Turzhitsky; Ramesh Wali; Andrew J Radosevich; Borko Jovanovic; Gary Della'Zanna; Asad Umar; David T Rubin; Michael J Goldberg; Laura Bianchi; Mart De La Cruz; Andrej Bogojevic; Irene B Helenowski; Luz Rodriguez; Robert Chatterton; Silvia Skripkauskas; Katherine Page; Christopher R Weber; Xiaoke Huang; Ellen Richmond; Raymond C Bergan; Vadim Backman
Journal:  Gut       Date:  2015-10-26       Impact factor: 23.059

7.  Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.

Authors:  Sobia Mujtaba; Roberd M Bostick
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-11       Impact factor: 2.566

8.  Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas.

Authors:  Temitope O Keku; Ahmad Amin; Joseph Galanko; Christopher Martin; Barbara Schliebe; Robert S Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

Review 9.  Could Aspirin and Diets High in Fiber Act Synergistically to Reduce the Risk of Colon Cancer in Humans?

Authors:  Pan Pan; Yi-Wen Huang; Kiyoko Oshima; Martha Yearsley; Jianying Zhang; Jianhua Yu; Mark Arnold; Li-Shu Wang
Journal:  Int J Mol Sci       Date:  2018-01-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.